NCT06744517

Brief Summary

Sprint interval training improves endurance performance and induces metabolic adaptations in muscle. Most research demonstrating these responses has been conducted in males, with limited studies evaluating changes to endurance performance and skeletal muscle oxidative capacity in females. Moreover, it is currently unknown if training in specific phases of the menstrual cycle influences adaptations to training. Thus, the purpose of the present study is to compare adaptations to 2 weeks of sprint interval training performed in the follicular vs. luteal phase of the menstrual cycle in healthy, eumenorrheic women.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
2mo left

Started Jan 2025

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jan 2025Jul 2026

First Submitted

Initial submission to the registry

December 16, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 20, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

1.5 years

First QC Date

December 16, 2024

Last Update Submit

April 27, 2026

Conditions

Keywords

exercisewomen

Outcome Measures

Primary Outcomes (1)

  • Endurance performance

    Time to completion and average power output during a 250kJ time trial

    Before and after 2 weeks of exercise training

Secondary Outcomes (7)

  • Skeletal muscle mitochondrial content

    Before and after 2 weeks of exercise training

  • Skeletal muscle mitochondrial enzyme activity

    Before and after 2 weeks of exercise training

  • Skeletal muscle capillarization

    Before and after 2 weeks of exercise training

  • Skeletal muscle lipid content

    Before and after 2 weeks of exercise training

  • Skeletal muscle protein synthesis

    Before and after 2 weeks of exercise training

  • +2 more secondary outcomes

Study Arms (2)

Follicular Phase Training

ACTIVE COMPARATOR

Exercise training in the follicular phase (\~days 1-14) of the participant's menstrual cycle

Other: Sprint Interval Training

Luteal Phase Training

EXPERIMENTAL

Exercise training in the luteal phase (\~days 15-28) of the participant's menstrual cycle

Other: Sprint Interval Training

Interventions

6 sessions of sprint interval training over 2 weeks. Each session involves 4-6 x 30 second Wingate sprints with 4 minutes of recovery in between on a stationary bike

Follicular Phase TrainingLuteal Phase Training

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participating in 150 min of moderate-vigorous physical activity/week
  • VO2peak of 'good' or above based on American College of Sport Medicine (ACSM) normative values(greater than 35.0ml/kg/min)
  • Body mass index (BMI) between 18-27 kg/m2
  • Performing 2-4 structured exercise sessions/week.
  • Weight stable (within ± 2kg for at least 6 months)
  • Non-smoker
  • Menstrual cycle length of 27-35 days
  • Minimal menstrual cycle length variability (less than 3 days)
  • Ovulating monthly evidenced by a positive urinary luteinizing hormone surge
  • Blood progesterone concentration greater than 16 nmol/L.

You may not qualify if:

  • Hormonal contraceptive use within the last 3 months
  • Polycystic ovarian syndrome (PCOS) or endometriosis
  • Failure to meet MC verification criteria.
  • Diagnosed with cardiovascular or metabolic disease, hyper- or hypogonadism, and/or PCOS
  • The use of medication for managing blood glucose or lipid metabolism
  • Current use of oral contraceptives or use within the last 3 months
  • Irregular menstrual cycles (\<27 days or \>35 days)
  • Pregnant or post-partum in the last 12 months, lactating or breast feeding within 3 months of the start of study, or menopausal
  • Recreational smoking tobacco
  • Inability to perform the study exercise protocols or follow the pre-trial dietary or physical activity controls
  • Taking medications affecting substrate metabolism (corticosteroids or nSAIDs)
  • Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goldring Centre for High Performance Sport

Toronto, Ontario, M5S 2C9, Canada

RECRUITING

MeSH Terms

Conditions

Motor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Jenna Gillen Assistant Professor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 16, 2024

First Posted

December 20, 2024

Study Start

January 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations